Back to Search
Start Over
Optimization of diarylpentadienones as chemotherapeutics for prostate cancer
- Publication Year :
- 2018
-
Abstract
- Our earlier studies indicate that (1E,4E)-1,5-bis(1-alkyl-1H-imidazol-2-yl)penta-1,4-diene-3-ones and (1E,4E)-1,5-bis(1-alkyl-1H-benzo[d] imidazol-2-yl)penta-1,4-diene-3-ones exhibit up to 121-fold greater antiproliferative potency than curcumin in human prostate cancer cell models, but only 2–10 fold increase in mouse plasma concentrations. The present study aims to further optimize them as anti-prostate cancer agents with both good potency and bioavailability. (1E,4E)-1,5-Bis(1H-imidazol-2-yl)penta-1,4-diene-3-one, the potential metabolic product of (1E,4E)-1,5-bis(1-alkyl-1H-imidazol-2-yl)penta-1,4-diene-3-ones, was synthesized and evaluated for its anti-proliferative activity. The promising potency of 1,5-bis(1-alkyl-1H-imidazol-2-yl)penta-1,4-diene-3-ones was completely abolished by removing the 1-alkyl group, suggesting the critical role of an appropriate group on the N1 position. We then envisioned that N-aryl substitution to exclude the C-H bond on the carbon adjacent to the N1 position (α-H) may increase the metabolic stability. Consequently, seven (1E,4E)-1,5-bis(1-aryl-1H-imidazol-2-yl)penta-1,4-dien-3-ones and three (1E,4E)-1,5-bis(1-aryl-1H-benzo[d]imidazol-2-yl)penta-1,4-dien-3-ones, as well as three (1E,4E)-1,5-bis(1-aryl-1H-pyrrolo[3,2-b]pyridine-2-yl)penta-1,4-dien-3-ones, were synthesized through a three-step transformation, including N-arylation via Ullmann condensation, formylation, and Horner-Wadsworth-Emmons reaction. Six optimal (1E,4E)-1,5-bis(1-aryl-1H-imidazol-2-yl)penta-1,4-dien-3-ones exhibit 24- to 375-fold improved potency as compared with curcumin. Replacement of the imidazole with bulkier benzoimidazole and 4-azaindole results in a substantial decrease in the potency. (1E,4E)-1,5-Bis(1-(2-methoxyphenyl)-1H-imidazol-2-yl)penta-1,4-dien-3-one (17d) was established as an optimal compound with both superior potency and good bioavailability that is sufficient to provide the therapeutic efficacy necessary to suppress in vivo tumor growth.
- Subjects :
- 0301 basic medicine
Ullmann condensation
Male
Curcumin
Clinical Biochemistry
Pharmaceutical Science
Antineoplastic Agents
Pharmacology
Biochemistry
Article
Rats, Sprague-Dawley
03 medical and health sciences
chemistry.chemical_compound
Prostate cancer
Structure-Activity Relationship
0302 clinical medicine
Drug Stability
In vivo
Cell Line, Tumor
Drug Discovery
medicine
Potency
Animals
Humans
Molecular Biology
Cell Proliferation
Organic Chemistry
Prostatic Neoplasms
Stereoisomerism
medicine.disease
Bioavailability
Formylation
Rats
Alkadienes
030104 developmental biology
chemistry
030220 oncology & carcinogenesis
Drug Design
Cancer cell
Microsomes, Liver
Molecular Medicine
Drug Screening Assays, Antitumor
Half-Life
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....e9648b73d15fcfd8b68e6d0c9e4ebdd1